The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats.
Open accessAbstract
Induction of protein kinase C (PKC) pathway in the vascular tissues by hyperglycemia has been associated with many of the cellular changes observed in the complications of diabetes. Recently, we have reported that the use of a novel, orally effective specific inhibitor of PKC beta isoform (LY333531) normalized many of the early retinal and renal hemodynamics in rat models of diabetes. In the present study, we have characterized a spectrum of biochemical and molecular abnormalities associated with chronic changes induced by glucose or diabetes in the cultured mesangial cells and renal glomeruli that can be prevented by LY333531. Hyperglycemia increased diacylglycerol (DAG) level in cultured mesangial cells exposed to high concentrations of glucose and activated PKC alpha and beta1 isoforms in the renal glomeruli of diabetic rats. The addition of PKC beta selective inhibitor (LY333531) to cultured mesangial cells inhibited activated PKC activities by high glucose without lowering DAG levels and LY333531 given orally in diabetic rats specifically inhibited the activation of PKC beta1 isoform without decreasing PKC alpha isoform activation. Glucose-induced increases in arachidonic acid release, prostaglandin E2 production, and inhibition of Na+-K+ ATPase activities in the cultured mesangial cells were completely prevented by the addition of LY333531. Oral feeding of LY333531 prevented the increased mRNA expression of TGF-beta1 and extracellular matrix components such as fibronectin and alpha1(IV) collagen in the glomeruli of diabetic rats in parallel with inhibition of glomerular PKC activity. These results suggest that the activation of PKC, predominately the beta isoform by hyperglycemia in the mesangial cells and glomeruli can partly contribute to early renal dysfunctions by alteration of prostaglandin production and Na+-K+ ATPase activity as well as the chronic pathological changes by the overexpression of TGF-beta1 and extracellular matrix components genes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
The molecular heterogeneity of protein kinase C and its implications for cellular regulation
Nishizuka, Y. (1988) · Nature · doi:10.1038/334661a0 · Cited by 4,171
Protein Kinase C: Structure, Function, and Regulation
Newton, A. C. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.48.28495 · Cited by 1,655
Kraft, A. S., & Anderson, W. B. (1983) · Nature · doi:10.1038/301621a0 · Cited by 1,291
Structural-functional relationships in diabetic nephropathy.
Mauer, S. M., Steffes, M. W., Ellis, E. N., Sutherland, D. E., Brown, D. M., & Goetz, F. C. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111523 · Cited by 1,209
Hyperglycemic Pseudohypoxia and Diabetic Complications
Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., Den Enden, M. V., Kilo, C., & Tilton, R. G. (1993) · Diabetes · doi:10.2337/diab.42.6.801 · Cited by 1,105
Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor
Ishii, H., Jirousek, M. R., Koya, D., Takagi, C., Xia, P., Clermont, A., Bursell, S.-E., Kern, T. S., Ballas, L. M., Heath, W. F., et al. (1996) · Science · doi:10.1126/science.272.5262.728 · Cited by 1,103
Self-citationNonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications
BROWNLEE, M., VLASSARA, H., & CERAMI, A. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-527 · Cited by 1,007
Flier, J. S., Underhill, L. H., Greene, D. A., Lattimer, S. A., & Sima, A. A. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703053161007 · Cited by 897
Yamamoto, T., Nakamura, T., Noble, N. A., Ruoslahti, E., & Border, W. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1814 · Cited by 830
Inoguchi, T., Battan, R., Handler, E., Sportsman, J. R., Heath, W., & King, G. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11059 · Cited by 740
Self-citationSharma, K., Jin, Y., Guo, J., & Ziyadeh, F. N. (1996) · Diabetes · doi:10.2337/diab.45.4.522 · Cited by 662
Ziyadeh, F. N., Sharma, K., Ericksen, M., & Wolf, G. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117004 · Cited by 597
Lipid activation of protein kinase C.
Bell, R. M., & Burns, D. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67698-2 · Cited by 555
Sharma, K., & Ziyadeh, F. N. (1995) · Diabetes · doi:10.2337/diab.44.10.1139 · Cited by 554
&NA; (1994) · Survey of Anesthesiology · doi:10.1097/00132586-199406000-00052 · Cited by 487
Ewart, H. S., & Klip, A. (1995) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1995.269.2.c295 · Cited by 460
Jirousek, M. R., Gillig, J. R., Gonzalez, C. M., Heath, W. F., McDonald, J. H., Neel, D. A., Rito, C. J., Singh, U., Stramm, L. E., Melikian-Badalian, A., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950588y · Cited by 339
Self-citationCraven, P. A., & DeRubertis, F. R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114066 · Cited by 319
Shiba, T., Inoguchi, T., Sportsman, J. R., Heath, W. F., Bursell, S., & King, G. L. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.5.e783 · Cited by 318
Self-citationA synthetic peptide substrate for selective assay of protein kinase C
Yasuda, I., Kishimoto, A., Tanaka, S.-I., Tominaga, M., Sakurai, A., & Nishizuka, Y. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90996-z · Cited by 286
Derubertis, F. R., & Craven, P. A. (1994) · Diabetes · doi:10.2337/diabetes.43.1.1 · Cited by 275
High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures
Ayo, S. H., Radnik, R., Garoni, J. A., Troyer, D. A., & Kreisberg, J. I. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.261.4.f571 · Cited by 255
Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium
Ayo, S. H., Radnik, R. A., Glass, W. F., Garoni, J. A., Rampt, E. R., Appling, D. R., & Kreisberg, J. I. (1991) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1991.260.2.f185 · Cited by 241
Expression of transforming growth factor-β1 during diabetic renal hypertrophy
Shankland, S. J., Scholey, J. W., Ly, H., & Thai, K. (1994) · Kidney International · doi:10.1038/ki.1994.291 · Cited by 233
Cell and Matrix Components of the Glomerular Mesangium in Type I Diabetes
Steffes, M. W., Bilous, R. W., Sutherland, D. E. R., & Mauer, S. M. (1992) · Diabetes · doi:10.2337/diab.41.6.679 · Cited by 227
Craven, P. A., Davidson, C. M., & DeRubertis, F. R. (1990) · Diabetes · doi:10.2337/diab.39.6.667 · Cited by 227
Heasley, L. E., & Johnson, G. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81841-5 · Cited by 214
Derubertis, F. R., & Craven, P. A. (1994) · Diabetes · doi:10.2337/diab.43.1.1 · Cited by 212
Studer, R. K., Craven, P. A., & DeRubertis, F. R. (1993) · Diabetes · doi:10.2337/diab.42.1.118 · Cited by 187
Xia, P., Kramer, R. M., & King, G. L. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118117 · Cited by 181
Self-citationSharma, K., & Ziyadeh, F. N. (1994) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1994.267.6.f1094 · Cited by 181
Schambelan, M., Blake, S., Sraer, J., Bens, M., Nivez, M. P., & Wahbe, F. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111714 · Cited by 170
Quantitative measurement of sn-1,2-diacylglycerols
Preiss, J. E., Loomis, C. R., Bell, R. M., & Niedel, J. E. (1987) · Methods in Enzymology · doi:10.1016/0076-6879(87)41077-x · Cited by 166
Craven, P. A., Caines, M. A., & DeRubertis, F. R. (1987) · Metabolism · doi:10.1016/0026-0495(87)90070-9 · Cited by 164
Structure-function relationships of cation binding in the Na+/K+-ATPase
Vasilets, L. A., & Schwarz, W. (1993) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(93)90012-d · Cited by 155
Ohno, S., Konno, Y., Akita, Y., Yano, A., & Suzuki, K. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39325-1 · Cited by 143
Williams, B., & Schrier, R. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116911 · Cited by 139
Mechanisms of Glucose-Enhanced Extracellular Matrix Accumulation in Rat Glomerular Mesangial Cells
Pugliese, G., Pricci, F., Pugliese, F. R., Mené, P., Lenti, L., Andreani, D., Galli, G., Casini, A., Bianchi, S., Rotella, C. M., et al. (1994) · Diabetes · doi:10.2337/diab.43.3.478 · Cited by 130
Williams, B., & Schrier, R. W. (1992) · Diabetes · doi:10.2337/diab.41.11.1464 · Cited by 119
Evidence for Existence of Polyol Pathway in Cultured Rat Mesangial Cells
Kikkawa, R., Umemura, K., Haneda, M., Arimura, T., Ebata, K., & Shigeta, Y. (1987) · Diabetes · doi:10.2337/diab.36.2.240 · Cited by 113
Kikkawa, R., Haneda, M., Uzu, T., Koya, D., Sugimoto, T., & Shigeta, Y. (1994) · Diabetologia · doi:10.1007/bf00404342 · Cited by 109
Self-citationAiello, L. P., Robinson, G. S., Lin, Y. W., Nishio, Y., & King, G. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6231 · Cited by 96
Self-citationWakisaka, M., Spiro, M. J., & Spiro, R. G. (1994) · Diabetes · doi:10.2337/diab.43.1.95 · Cited by 73
Role of transforming growth factor-beta in diabetic glomerulosclerosis and renal hypertrophy.
Fn, Z., & Sharma, K. (1995) · PubMed · Cited by 51
WITH THE TECHNICAL ASSISTANCE OF .
Gertrudis, S. (1959) · Cited by 43
Negrete, H. O., Studer, R. K., Craven, P. A., & DeRubertis, F. R. (1995) · Diabetes · doi:10.2337/diab.44.3.335 · Cited by 25
Cited by
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Molecular Understanding of Hyperglycemia's Adverse Effects for Diabetic Complications
Sheetz, M. J. (2002) · JAMA · doi:10.1001/jama.288.20.2579 · Cited by 1,002
Metadata
- Authors
- Koya, D., Jirousek, M. R., Lin, Y. W., Ishii, H., Kuboki, K., & King, G. L.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-07-01
- Volume
- 100
- Issue
- 1
- Pages
- 115-126
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2045926020
- Cited by
- 536
- References
- 49
- FWCI
- 18.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.